Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New targeted combo aims to outsmart KRAS lung cancer

NCT ID NCT07190248

Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 15, 2026 · Updated 15 times

Summary

This Phase 3 trial tests whether adding the targeted drug calderasib to the immunotherapy pembrolizumab helps people with a specific KRAS G12C-mutated lung cancer live longer without their cancer growing. About 675 participants with advanced non-squamous non-small cell lung cancer will receive either the new combo or standard chemotherapy plus pembrolizumab. The study is currently recruiting.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
calderasib (MK-1084) and pembrolizumab with berahyaluronidase alfa
What this could lead to
If successful, this combination could offer a new first-line treatment option that delays cancer growth and extends survival for people with KRAS G12C-mutant lung cancer.
What could go wrong
This is an early-stage Phase 3 trial, so results are not yet known. The experimental combination may not work better than chemotherapy, and side effects from the drugs could be serious.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 675 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Aug 2032

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Has nonsquamous NSCLC (Stage IIIB, Stage IIIC) not eligible for curative resection or chemoradiation or Stage IV: M1a, M1b, or M1c * If human immunodeficiency virus (HIV) positive, must have well controlled HIV on antiretroviral therapy (ART) Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * Has diagnosis of small cell lung cancer or, for mixed tumors, presence of small cell elements * Has active inflammatory bowel disease requiring immunosuppressive medication or previous clear history of inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis, or chronic diarrhea) * Has uncontrolled, significant cardiovascular disease or cerebrovascular disease * Has a gastrointestinal disorder affecting absorption * Is HIV positive and has a history of Kaposi's sarcoma and/or Multicentric Castleman's Disease * Has received prior systemic anticancer therapy for their advanced or metastatic NSCLC * Has known additional malignancy that is progressing or has required active treatment within the past 3 years * Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis * Has active autoimmune disease that has required systemic treatment in the past 2 years * History of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease * Has active infection requiring systemic therapy except those specified by protocol * Has history of stem cell/solid organ transplant * Has not adequately recovered from major surgery or has ongoing surgical complications

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KRAS G12C-mutant advanced or metastatic nonsquamous non-small cell lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung adenocarcinoma non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Non-small cell lung cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    207 sites in 30 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • A.O.R.N. Antonio Cardarelli ( Site 1810)

    RECRUITING

    Naples, 80131, Italy

  • AFFILIATED CANCER HOSPITAL AND INSTITUTE OF GUANGZHOU MEDICAL UNIVERSITY ( Site 2743)

    RECRUITING

    Guangzhou, Guangdong, 510095, China

  • AOU Careggi ( Site 1801)

    RECRUITING

    Florence, Tuscany, 50134, Italy

  • AOU Renato Dulbecco ( Site 1804)

    RECRUITING

    Catanzaro, 88100, Italy

  • ASST Grande Ospedale Metropolitano Niguarda ( Site 1817)

    RECRUITING

    Milan, 20162, Italy

  • Adana Medical Park Seyhan Hastanesi ( Site 2407)

    RECRUITING

    Seyhan, Adana, 01140, Turkey (Türkiye)

  • Affiliated Cancer Hospital of Guangxi Medical University ( Site 2704)

    RECRUITING

    Nanning, Guangxi, 530021, China

  • Agios Andreas Hospital Patras ( Site 1407)

    RECRUITING

    Pátrai, Achaia, 263 35, Greece

  • Aichi Cancer Center ( Site 2813)

    RECRUITING

    Nagoya, Aichi-ken, 464-8681, Japan

  • Amphia Ziekenhuis, locatie Breda Molengracht ( Site 1907)

    RECRUITING

    Breda, North Brabant, 4818 CK, Netherlands

  • Anhui Provincial Cancer Hospital ( Site 2708)

    RECRUITING

    Hefei, Anhui, 230031, China

  • Ankara Bilkent Sehir Hastanesi ( Site 2401)

    RECRUITING

    Ankara, 06800, Turkey (Türkiye)

  • Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Trento ( Site 1809)

    RECRUITING

    Verona, 37126, Italy

  • Azienda Santiaria dell'Alto Adige, comprensorio di Bolzano ( Site 1818)

    RECRUITING

    Bolzano, Bozen, 39100, Italy

  • Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII ( Site 1811)

    RECRUITING

    Bergamo, Lombardy, 24127, Italy

  • Bakirkoy Dr. Sadi Konuk Training and Research Hospital ( Site 2408)

    RECRUITING

    Istanbul, 34147, Turkey (Türkiye)

  • Beijing Cancer hospital-Thoracic Cancer Department A ( Site 2700)

    RECRUITING

    Beijing, Beijing Municipality, 100142, China

  • Beijing Peking Union Medical College Hospital ( Site 2702)

    RECRUITING

    Beijing, Beijing Municipality, 100730, China

  • Blue Ridge Cancer Care ( Site 0144)

    RECRUITING

    Roanoke, Virginia, 24014, United States

  • Bradfordhill ( Site 0501)

    RECRUITING

    Santiago, Region M. de Santiago, 8420383, Chile

  • CANCER TREAMTENT CLINIC AND CLINICAL TRIALS SA DE CV ( Site 0801)

    RECRUITING

    Guadalajara, Jalisco, 44260, Mexico

  • CEMAIC ( Site 0309)

    RECRUITING

    Córdoba, X5008AAC, Argentina

  • CEPEN - Centro de Pesquisa e Ensino em Oncologia de Santa Catarina ( Site 0410)

    RECRUITING

    Florianópolis, Santa Catarina, 88020-210, Brazil

  • CHU Caen ( Site 1212)

    RECRUITING

    Caen, Calvados, 14000, France

  • CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA ( Site 0412)

    RECRUITING

    Fortaleza, Ceará, 60336-232, Brazil

  • Cengild G.I. Medical Centre ( Site 3112)

    RECRUITING

    Kuala Lumpur, 592000, Malaysia

  • Central Alabama Research ( Site 0108)

    RECRUITING

    Birmingham, Alabama, 35209, United States

  • Centre Hospitalier Metropole Savoie Site de Chambery ( Site 1208)

    RECRUITING

    Chambéry, Savoie, 73011, France

  • Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois ( Site 1209)

    RECRUITING

    Vandœuvre-lès-Nancy, Meurthe-et-Moselle, 54500, France

  • Centre Hospitalier de Pau ( Site 1217)

    RECRUITING

    Pau, Pyrenees-Atlantiques, 64000, France

  • Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa ( Site 0400)

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90110-270, Brazil

  • Centro Integral De Oncologia Gastrointestinal Y Hemato-Oncologia De Guatemala, S. A ( Site 3802)

    RECRUITING

    Guatemala City, 01010, Guatemala

  • Centro de Estudios Clínicos SAGA ( Site 0503)

    RECRUITING

    Santiago, Region M. de Santiago, 7500653, Chile

  • Centro de Investigacion Clinica de Oaxaca ( Site 0813)

    RECRUITING

    Oaxaca City, Oaxaca, 68020, Mexico

  • Centrul de Oncologie "Sfântul Nectarie" ( Site 2107)

    RECRUITING

    Craiova, Dolj, 200347, Romania

  • Chang Gung Memorial Hospital- Chiayi ( Site 3611)

    RECRUITING

    Chiayi City, Chiayi, 613, Taiwan

  • Chiba University Hospital ( Site 2812)

    RECRUITING

    Chiba, 260-8677, Japan

  • Chongqing University Cancer Hospital ( Site 2736)

    RECRUITING

    Chongqing, Sichuan, 400030, China

  • Chonnam National University Hwasun Hospital ( Site 3502)

    RECRUITING

    Jeollanam-do, Jeonranamdo, 58128, South Korea

  • Chungnam National University Hospital ( Site 3503)

    RECRUITING

    Daejeon, Taejon-Kwangyokshi, 35015, South Korea

  • Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia ( Site 0607)

    RECRUITING

    Bogotá, Bogota D.C., 111321, Colombia

  • Clinica Integral Internacional de Oncología ( Site 0812)

    RECRUITING

    Puebla City, 72530, Mexico

  • Clinical Chc Montlégia ( Site 3901)

    RECRUITING

    Liège, 4000, Belgium

  • Clinique de l'Europe ( Site 1213)

    RECRUITING

    Amiens, Somme, 80000, France

  • Communal noncommercial enterprise of Lviv regional council "Lviv oncological regional therapeutical ( Site 2507)

    RECRUITING

    Lviv, Lviv Oblast, 79031, Ukraine

  • Complejo Hospitalario Universitario A Coruna ( Site 2207)

    RECRUITING

    A Coruña, La Coruna, 15006, Spain

  • Cross Cancer Institute ( Site 0203)

    RECRUITING

    Edmonton, Alberta, T6G 1Z2, Canada

  • Delta Health Care SRL ( Site 2108)

    RECRUITING

    Bucharest, 014142, Romania

  • Ehime University Hospital ( Site 2800)

    RECRUITING

    Tōon, Ehime, 791-0295, Japan

  • Elisabeth-TweeSteden Ziekenhuis ( Site 1906)

    RECRUITING

    Tilburg, North Holland, 5022 GC, Netherlands

  • Errikos Dunant Hospital Center ( Site 1408)

    RECRUITING

    Athens, Attica, 115 26, Greece

  • FALP ( Site 0500)

    RECRUITING

    Santiago, Region M. de Santiago, 7500921, Chile

  • Faculdade de Medicina do ABC ( Site 0411)

    RECRUITING

    Santo André, São Paulo, 09060-870, Brazil

  • Fujian Provincial Cancer Hospital ( Site 2706)

    RECRUITING

    Fuzhou, Fujian, 350014, China

  • Fujita Health University Hospital ( Site 2807)

    RECRUITING

    Toyoake, Aichi-ken, 470-1192, Japan

  • Gazi Universitesi Tip Fakultesi ( Site 2404)

    RECRUITING

    Ankara, 06560, Turkey (Türkiye)

  • General Hospital of Athens "Laiko" ( Site 1402)

    RECRUITING

    Athens, Attica, 11526, Greece

  • Genesis Care- Campbelltown ( Site 2907)

    RECRUITING

    Campbelltown, New South Wales, 2560, Australia

  • Groupe Hospitalier Paris Saint Joseph ( Site 1215)

    RECRUITING

    Paris, 75014, France

  • Grupo Médico ASSET SC ( Site 0811)

    RECRUITING

    Benito Juárez, Mexico City, 03100, Mexico

  • Gunma Prefectural Cancer Center ( Site 2802)

    ACTIVE_NOT_RECRUITING

    Ōta, Gunma, 373-8550, Japan

  • HOSPITAL CLÍNIC DE BARCELONA ( Site 2201)

    RECRUITING

    Barcelona, Catalonia, 08036, Spain

  • HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA ( Site 2202)

    RECRUITING

    Majadahonda, Madrid, Comunidad de, 28220, Spain

  • Hacettepe Universite Hastaneleri ( Site 2400)

    RECRUITING

    Altindağ, Ankara, 06230, Turkey (Türkiye)

  • Hematology Oncology Associates of Fredericksburg ( Site 9550)

    RECRUITING

    Fredericksburg, Virginia, 22408, United States

  • Henan Cancer Hospital ( Site 2746)

    RECRUITING

    Zhengzhou, Henan, 450008, China

  • Hirosaki University Hospital ( Site 2818)

    RECRUITING

    Hirosaki, Aomori, 036-8563, Japan

  • Hiroshima City Hiroshima Citizens Hospital ( Site 2821)

    RECRUITING

    Hiroshima, 730-8518, Japan

  • Hopital Europeen Marseille ( Site 1207)

    RECRUITING

    Marseille, Bouches-du-Rhone, 13003, France

  • Hospital Alemao Oswaldo Cruz ( Site 0413)

    RECRUITING

    São Paulo, São Paulo, 01327-001, Brazil

  • Hospital General Universitario de Valencia ( Site 2204)

    RECRUITING

    Valencia, Valenciana, Comunitat, 46014, Spain

  • Hospital Italiano de Cordoba ( Site 0308)

    RECRUITING

    Córdoba, 5000, Argentina

  • Hospital Nacional Edgardo Rebagliati Martins ( Site 0903)

    RECRUITING

    Lima, 15072, Peru

  • Hospital Pulau Pinang ( Site 3108)

    RECRUITING

    George Town, Pulau Pinang, 10990, Malaysia

  • Hospital Santa Rita de Cassia ( Site 0403)

    RECRUITING

    Vitória, Espírito Santo, 29043-260, Brazil

  • Hospital Tengku Ampuan Afzan ( Site 3109)

    RECRUITING

    Kuantan, Pahang, 25100, Malaysia

  • Hospital Universitario Ramon y Cajal ( Site 2203)

    RECRUITING

    Madrid, 28034, Spain

  • Hospital Universitario San Ignacio ( Site 0604)

    RECRUITING

    Bogotá, Bogota D.C., 110231, Colombia

  • Hospital Universitario Virgen de Valme ( Site 2205)

    RECRUITING

    Seville, 41014, Spain

  • Hospital Wanita and Kanak Kanak Sabah ( Site 3110)

    RECRUITING

    Kota Kinabalu, Sabah, 88996, Malaysia

  • Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto USP ( Site 0419)

    RECRUITING

    Ribeirão Preto, São Paulo, 14048-900, Brazil

  • Hubei Cancer Hospital ( Site 2721)

    RECRUITING

    Wuhan, Hubei, 430079, China

  • Hunan Cancer Hospital ( Site 2710)

    RECRUITING

    Changsha, Hunan, 410013, China

  • Hôpital Européen Georges Pompidou ( Site 1214)

    RECRUITING

    Paris, 75015, France

  • IBCC - Núcleo de Pesquisa e Ensino ( Site 0417)

    RECRUITING

    São Paulo, 04014-002, Brazil

  • IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0902)

    RECRUITING

    Lima, 15036, Peru

  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 1807)

    RECRUITING

    Meldola, Forli-Cesena, 47014, Italy

  • Indiana University Health Arnett Cancer Center ( Site 0116)

    RECRUITING

    Lafayette, Indiana, 47904, United States

  • Institut Català d'Oncologia (ICO) - Badalona ( Site 2200)

    RECRUITING

    Badalona, Catalonia, 08916, Spain

  • Instituto Alexander Fleming ( Site 0311)

    RECRUITING

    Ciudad Autónoma de Buenos Aires, Buenos Aires, C1426ANZ, Argentina

  • Instituto Nacional de Cancerologia. ( Site 0808)

    RECRUITING

    Mexico City, 14080, Mexico

  • Instituto de Investigaciones Clinicas Mar del Plata ( Site 0300)

    RECRUITING

    Mar del Plata, Buenos Aires, B7600FZO, Argentina

  • Institutul Oncologic Prof. Dr. I Chiricuta ( Site 2103)

    RECRUITING

    Cluj-Napoca, Cluj, 400015, Romania

  • Istituto Clinico Humanitas ( Site 1812)

    RECRUITING

    Rozzano, Milano, 20089, Italy

  • JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 2745)

    RECRUITING

    Jiamusi, Heilongjiang, 154007, China

  • Jiangxi Cancer Hospital ( Site 2725)

    RECRUITING

    Nanchang, Jiangxi, 330029, China

  • John Theurer Cancer Center at Hackensack University Medical Center ( Site 0152)

    RECRUITING

    Hackensack, New Jersey, 07601, United States

  • Kanagawa Cancer Center ( Site 2820)

    RECRUITING

    Yokohama, Kanagawa, 241-8515, Japan

  • Kanazawa University Hospital ( Site 2805)

    RECRUITING

    Kanazawa, Ishikawa-ken, 920-8641, Japan

  • Kansai Medical University Hospital ( Site 2809)

    RECRUITING

    Hirakata, Osaka, 573-1191, Japan

  • Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 1001)

    RECRUITING

    Vienna, 1210, Austria

  • Klinik fur Hamatologie und Onkologie Hirslanden Zurich ( Site 4001)

    RECRUITING

    Zurich, 8032, Switzerland

  • Klinikum Klagenfurt am Wörthersee ( Site 1002)

    RECRUITING

    Klagenfurt, Carinthia, 9020, Austria

  • Kobe City Medical Center General Hospital ( Site 2811)

    RECRUITING

    Kobe, Hyōgo, 650-0047, Japan

  • Korea University Guro Hospital ( Site 3505)

    RECRUITING

    Seoul, 08308, South Korea

  • Kurume University Hospital ( Site 2815)

    RECRUITING

    Kurume, Fukuoka, 830-0011, Japan

  • Kyung Hee University Medical Center ( Site 3500)

    RECRUITING

    Seoul, 02447, South Korea

  • Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" ( Site 0800)

    RECRUITING

    Monterrey, Nuevo León, 64460, Mexico

  • Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0111)

    RECRUITING

    Lancaster, Pennsylvania, 17601, United States

  • Leicester Royal Infirmary ( Site 2610)

    RECRUITING

    Leicester, LE1 5WW, United Kingdom

  • LinYi Cancer Hospital ( Site 2737)

    RECRUITING

    Linyi, Shandong, 276000, China

  • ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 2517)

    RECRUITING

    Rivne, Rivne Oblast, 33010, Ukraine

  • MEDI-K ( Site 3803)

    ACTIVE_NOT_RECRUITING

    Guatemala City, 01009, Guatemala

  • MacKay Memorial Hospital ( Site 3609)

    RECRUITING

    Taipei, 10449, Taiwan

  • Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi ( Site 2405)

    RECRUITING

    Istanbul, 34899, Turkey (Türkiye)

  • Mater Hospital Brisbane ( Site 2906)

    RECRUITING

    South Brisbane, Queensland, 4101, Australia

  • Medizinische Universität Graz-Klinische Abteilung für Pulmonologie ( Site 1005)

    RECRUITING

    Graz, Styria, 8036, Austria

  • Meir Medical Center. ( Site 1702)

    RECRUITING

    Kfar Saba, 4428164, Israel

  • Metropolitan General Hospital ( Site 1400)

    RECRUITING

    Athens, Attica, 155 62, Greece

  • Mount Sinai Cancer Center ( Site 0137)

    COMPLETED

    Miami Beach, Florida, 33140, United States

  • Municipal Enterprise "Bukovinian сlinical oncology сenter" ( Site 2504)

    RECRUITING

    Chernivtsi, Chernivetska Oblast, 58013, Ukraine

  • Municipal non-profit enterprise'Odesa Regional Clinical Hospital'of Odesa Regional Council ( Site 2518)

    RECRUITING

    Odesa, Odesa Oblast, 65025, Ukraine

  • Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 2715)

    ACTIVE_NOT_RECRUITING

    Nanjing, Jiangsu, 210000, China

  • Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2012)

    RECRUITING

    Gliwice, Silesian Voivodeship, 44-102, Poland

  • National Center for Global Health and Medicine ( Site 2806)

    RECRUITING

    Shinjuku, Tokyo, 162-8655, Japan

  • National Cheng Kung University Hospital ( Site 3604)

    RECRUITING

    Tainan, 704, Taiwan

  • National Hospital Organization Himeji Medical Center ( Site 2827)

    RECRUITING

    Himeji, Hyōgo, 670-8520, Japan

  • National Hospital Organization Kinki-chuo Chest Medical Center ( Site 2822)

    RECRUITING

    Sakai, Osaka, 591-8555, Japan

  • National Hospital Organization Kyushu Medical Center ( Site 2801)

    RECRUITING

    Fukuoka, 810-8563, Japan

  • National Hospital Organization Ureshino Medical Center ( Site 2817)

    RECRUITING

    Ureshino, Saga-ken, 843-0393, Japan

  • National Taiwan University Cancer Center (NTUCC) ( Site 3601)

    RECRUITING

    Taipei, 106, Taiwan

  • New England Cancer Specialists ( Site 0139)

    RECRUITING

    Westbrook, Maine, 04092, United States

  • New York Oncology Hematology, P.C. ( Site 0119)

    RECRUITING

    Albany, New York, 12206, United States

  • Nippon Medical School Hospital ( Site 2819)

    RECRUITING

    Bunkyo, Tokyo, 113-8603, Japan

  • Northern Beaches Hospital ( Site 2905)

    RECRUITING

    Frenchs Forest, New South Wales, 2086, Australia

  • Oncosalud ( Site 0901)

    RECRUITING

    Lima, 15036, Peru

  • Orszagos Koranyi Pulmonologiai Intezet ( Site 1501)

    RECRUITING

    Budapest, Pest County, 1121, Hungary

  • Osaka Medical and Pharmaceutical University Hospital ( Site 2810)

    RECRUITING

    Takatsuki, Osaka, 569-8686, Japan

  • Osaka Metropolitan University Hospital ( Site 2826)

    RECRUITING

    Osaka, 545-8586, Japan

  • Ospedale San Giuseppe Moscati ( Site 1816)

    RECRUITING

    Statte, Taranto, 74010, Italy

  • P.O. "S. Maria della Misericordia" Azienda Sanitaria Universitaria Friuli Centrale ( Site 1813)

    RECRUITING

    Udine, Friuli Venezia Giulia, 33100, Italy

  • Papageorgiou General Hospital of Thessaloniki ( Site 1403)

    RECRUITING

    Thessaloniki, 564 29, Greece

  • Peninsula & South Eastern Haematology and Oncology Group ( Site 2908)

    RECRUITING

    Frankston, Victoria, 3199, Australia

  • Policlinico San Matteo ( Site 1802)

    RECRUITING

    Pavia, 27100, Italy

  • Promotora Médica Las Américas S.A. ( Site 0608)

    RECRUITING

    Medellín, Antioquia, 050025, Colombia

  • Pusan National University Hospital ( Site 3501)

    RECRUITING

    Busan, Pusan-Kwangyokshi, 49241, South Korea

  • Pusan National University Yangsan Hospital ( Site 3504)

    RECRUITING

    Yangsan, Kyongsangnam-do, 50612, South Korea

  • Queen Elizabeth Hospital Birmingham ( Site 2612)

    RECRUITING

    Birmingham, B15 2TH, United Kingdom

  • Real Hospital Portugues ( Site 0418)

    RECRUITING

    Recife, Pernambuco, 52010075, Brazil

  • Reformatus Pulmonologiai Centrum ( Site 1503)

    RECRUITING

    Törökbálint, Pest County, 2045, Hungary

  • Royal Cornwall Hospital ( Site 2614)

    RECRUITING

    Truro, Cornwall, TR1 2LJ, United Kingdom

  • Royal Free Hospital ( Site 2601)

    RECRUITING

    London, London, City of, NW3 2QG, United Kingdom

  • SC MNT Healthcare Europe SRL ( Site 2105)

    RECRUITING

    Bucharest, 013975, Romania

  • SC ONCO CARD SRL ( Site 2109)

    RECRUITING

    Brasov, 500052, Romania

  • SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2101)

    RECRUITING

    Florești, Cluj, 407280, Romania

  • Saiseikai Kumamoto Hospital ( Site 2816)

    RECRUITING

    Kumamoto, 861-4193, Japan

  • Saiseikai Matsusaka Municipal Hospital ( Site 2808)

    RECRUITING

    Matsusaka, Mie-ken, 515-8544, Japan

  • Sarawak General Hospital ( Site 3101)

    RECRUITING

    Kuching, Sarawak, 93586, Malaysia

  • Scientia Investigacion Clinica S.C. ( Site 0804)

    RECRUITING

    Chihuahua City, 31207, Mexico

  • Servicios Médicos Oncológicos ( Site 3804)

    RECRUITING

    Guatemala City, 1010, Guatemala

  • Shaare Zedek Medical Center ( Site 1706)

    RECRUITING

    Jerusalem, 9103102, Israel

  • Shalimov Institute of Surgery and Transplantation Oncology department ( Site 2512)

    RECRUITING

    Kyiv, 02000, Ukraine

  • Shanghai Pulmonary Hospital-Oncology Department ( Site 2723)

    RECRUITING

    Shanghai, Shanghai Municipality, 200433, China

  • Shanxi Cancer Hospital ( Site 2728)

    RECRUITING

    Taiyuan, Shanxi, 030013, China

  • Sheba Medical Center ( Site 1700)

    RECRUITING

    Ramat Gan, 5265601, Israel

  • Sichuan Cancer Hospital. ( Site 2739)

    RECRUITING

    Chengdu, Sichuan, 610213, China

  • Sir Run Run Shaw Hospital ( Site 2731)

    RECRUITING

    Hangzhou, Zhejiang, 310015, China

  • Sourasky Medical Center ( Site 1705)

    RECRUITING

    Tel Aviv, 6423906, Israel

  • Spitalul Clinic Colțea ( Site 2102)

    RECRUITING

    Bucharest, Bucharest, 030171, Romania

  • Spitalul Municipal Schuller Ploiești ( Site 2106)

    RECRUITING

    Ploieşti, Prahova, 100337, Romania

  • St. Charles Health System, Inc ( Site 0146)

    RECRUITING

    Bend, Oregon, 97701, United States

  • St. Marianna University Hospital ( Site 2814)

    RECRUITING

    Kawasaki, Kanagawa, 216-8511, Japan

  • Stadtspital Zürich Triemli - Klinik für Medizinische Onkologie und Hämatologie ( Site 4000)

    RECRUITING

    Zurich, 8063, Switzerland

  • Stamford Hospital ( Site 0126)

    RECRUITING

    Stamford, Connecticut, 06902, United States

  • Sultan Ismail Hospital ( Site 3103)

    RECRUITING

    Johor Bahru, Johor, 81100, Malaysia

  • Sunway Medical Centre ( Site 3106)

    RECRUITING

    Petaling Jaya, Selangor, 47500, Malaysia

  • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi ( Site 2403)

    RECRUITING

    Istanbul, 34722, Turkey (Türkiye)

  • Taipei Medical University Shuang Ho Hospital ( Site 3602)

    RECRUITING

    New Taipei City, 235, Taiwan

  • Taizhou Hospital of Zhejiang Province-Respiratory ( Site 2724)

    RECRUITING

    Taizhou, Zhejiang, 317000, China

  • Takarazuka City Hospital ( Site 2828)

    RECRUITING

    Takarazuka, Hyōgo, 665-0827, Japan

  • The First Affiliated Hospital of Fujian Medical University ( Site 2701)

    RECRUITING

    Fujian, Fujian, 350005, China

  • The First Affiliated Hospital of Xi'an Jiaotong University ( Site 2729)

    RECRUITING

    Xi'an, Shaanxi, 710061, China

  • The First Affiliated Hospital of Xiamen University ( Site 2717)

    RECRUITING

    Fuzhou, Fujian, 361003, China

  • The First Affiliated Hospital, Zhejiang University ( Site 2716)

    RECRUITING

    Hangzhou, Zhejiang, 310003, China

  • The First Affiliated Hospital.Sun Yat-sen University ( Site 2714)

    RECRUITING

    Guangzhou, Guangdong, 510080, China

  • The Prince Charles Hospital ( Site 2903)

    RECRUITING

    Brisbane, Queensland, 4032, Australia

  • Toho University Omori Medical Center ( Site 2825)

    RECRUITING

    Ōta-ku, Tokyo, 143-8541, Japan

  • Tohoku University Hospital ( Site 2804)

    RECRUITING

    Sendai, Miyagi, 980-8574, Japan

  • Tokyo Medical University Hospital ( Site 2829)

    RECRUITING

    Shinjuku, Tokyo, 160-0023, Japan

  • Tokyo Metropolitan Komagome Hospital ( Site 2823)

    RECRUITING

    Bunkyo, Tokyo, 113-8677, Japan

  • Tongji Hospital Tongji Medical,Science & Technology ( Site 2722)

    RECRUITING

    Wuhan, Hubei, 430030, China

  • Trakya Universitesi Tip Fakultesi ( Site 2406)

    RECRUITING

    Edirne, 22030, Turkey (Türkiye)

  • Tri-Service General Hospital ( Site 3603)

    RECRUITING

    Taipei, 114, Taiwan

  • Universal Clinic Oberig ( Site 2506)

    RECRUITING

    Kyiv, 03057, Ukraine

  • Universitair Medisch Centrum Utrecht ( Site 1901)

    RECRUITING

    Utrecht, 3584 CX, Netherlands

  • University Malaya Medical Centre ( Site 3107)

    RECRUITING

    Wilayah Persekutuan, Kuala Lumpur, 59100, Malaysia

  • University Medical Center Groningen ( Site 1908)

    RECRUITING

    Groningen, 9713 GZ, Netherlands

  • University of Connecticut Health Center ( Site 0130)

    RECRUITING

    Farmington, Connecticut, 06030-8010, United States

  • VITAZ ( Site 3902)

    RECRUITING

    Sint-Niklaas, Oost-Vlaanderen, 9100, Belgium

  • Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 2004)

    RECRUITING

    Olsztyn, Warmian-Masurian Voivodeship, 10-357, Poland

  • West China Hospital Sichuan University ( Site 2735)

    RECRUITING

    Chengdu, Sichuan, 611135, China

  • Wilmot Cancer Institute ( Site 0141)

    RECRUITING

    Rochester, New York, 14642, United States

  • Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 2008)

    RECRUITING

    Przemyśl, Podkarpackie Voivodeship, 37-700, Poland

  • Xiangya Hospital Central South University ( Site 2741)

    RECRUITING

    Changsha, Hunan, 410008, China

  • Yitzhak Shamir Medical Center. ( Site 1709)

    RECRUITING

    Beer Ya Akov, 7033001, Israel

  • Yokohama Municipal Citizen's Hospital ( Site 2824)

    RECRUITING

    Yokohama, Kanagawa, 221-0855, Japan

  • Yunnan Province Cancer Hospital ( Site 2734)

    RECRUITING

    Kunming, Yunnan, 650118, China

  • Zhejiang Cancer Hospital ( Site 2727)

    RECRUITING

    Hangzhou, Zhejiang, 310022, China

  • Zhujiang Hospital of Southern Medical University ( Site 2744)

    RECRUITING

    Guangzhou, Guangdong, 510280, China

  • Zhytomyr Regional Oncology Center ( Site 2519)

    RECRUITING

    Zhytomyr, Zhytomyr Oblast, 10002, Ukraine

  • Ziekenhuis Oost-Limburg, Campus St.-Jan ( Site 3903)

    RECRUITING

    Genk, Limburg, 3600, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.